Sanofi/Lexicon diabetes therapy gets PDUFA date

Sanofi (Euronext:SAN; NYSE:SNY) and partner Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) said FDA accepted an

Read the full 139 word article

User Sign In